Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Low iron levels are linked to more hair loss in non-menopausal women.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Pregnancy can cause unique skin issues, some of which may risk the mother and baby's health and need careful treatment.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.